Weijian C. Guo

130 Dong' An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.

Matching-adjusted indirect comparison of fruquintinib versus ramucirumab in advanced gastric or gastroesophageal junction adenocarcinoma.

Journal: Journal of comparative effectiveness research

Published: August 12, 2026

A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer.

A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer.

Journal: Oncology research

Published: April 21, 2026

Colorectal cancer detection using noncontrast CT and deep learning: a multicenter and international cohort study.

Colorectal cancer detection using noncontrast CT and deep learning: a multicenter and international cohort study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 18, 2025

Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.

Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.

Journal: Cancer biology & medicine

Published: February 22, 2025

Development and validation of a gastric cancer prognostic model utilizing lymphatic endothelial cell-related genes.

Development and validation of a gastric cancer prognostic model utilizing lymphatic endothelial cell-related genes.

Journal: Diagnostic pathology

Published: February 11, 2025

Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer.

Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer.

Journal: Cancer medicine

Published: September 15, 2024

Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study.

Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study.

Journal: Advances in therapy

Published: June 19, 2024

68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer.

68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer.

Journal: The Journal of clinical investigation

Published: April 15, 2024

Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial.

Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial.

Journal: Nature medicine

Published: March 05, 2024

Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer.

Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 29, 2024

LINC01764 promotes colorectal cancer cells proliferation, metastasis, and 5-fluorouracil resistance by regulating glucose and glutamine metabolism via promoting c-MYC translation.

LINC01764 promotes colorectal cancer cells proliferation, metastasis, and 5-fluorouracil resistance by regulating glucose and glutamine metabolism via promoting c-MYC translation.

Journal: MedComm

Published: November 25, 2023

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.

A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer.

Journal: Therapeutic advances in medical oncology

Published: September 07, 2023

Showing 1-12 of 92

Last Updated: 09/26/2026